Neuroscience Fall 2025 Seminar Series – Michelle Monje
Michelle Monje, MD, PhD is a physician-scientist, neuroscientist, and neurooncologist at Stanford University, where she has developed new treatments for brain cancer since 2011. Her interests are neurodevelopment, pediatric gliogenesis, chemobrain,

